Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-LEVOCLOPERASTINE Suspension Tablets (LEVOCLOPERASTINE FENDIZOATE IP EQ. TO LEVOCLOPERASTINE HCL SUSPENSION 35.) within the Others therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.
| Product Name | VEERIX-LEVOCLOPERASTINE Suspension Tablets |
| Active Composition | LEVOCLOPERASTINE FENDIZOATE IP EQ. TO LEVOCLOPERASTINE HCL SUSPENSION 35. |
| Therapeutic Segment | Others |
| Dosage Form | Tablets |
| Primary Packaging | 100ml / 200ml |
| Quality Standard | IP / BP / USP Pharmacopeial Standard, WHO-GMP Certified |
| Manufacturing Facility | Tahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu |
| Regulatory Documentation | Batch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3 |
Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-LEVOCLOPERASTINE Suspension Tablets in the Others class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.